Brace yourself for soaring drug spending costs—and feel free toblame Obamacare.
A HealthPocket study finds that copayments and co-insurance feesfor drugs increased an average of 34 percent under the PatientProtection and Affordable Care Act. And enrollees who usebrand-name drugs and specialty drugs are getting hit much harderwith rising costs.
That was the finding after researchers examined new PPACA healthplans from 46 states and compared the prices to those from thepre-PPACA individual insurance market.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
